|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 223.90 EUR | +3.18% |
|
-8.98% | -6.16% |
| 01:33pm | AlphaValue/Baader Europe Upgrades UCB to Add, Trims PT | MT |
| 07-30 | UCB SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UCB | Biopharmaceuticals | +3.18% | -8.98% | -6.16% | +17.56% | +143.69% | 47.63B |  | |  |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
